| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-11 |
| mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-11 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-10 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-10 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
5e-10 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-09 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-09 |
| mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-09 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-08 |